316 related articles for article (PubMed ID: 20438389)
1. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani.
Ranawaka RR; Weerakoon HS
J Dermatolog Treat; 2010 Sep; 21(5):286-93. PubMed ID: 20438389
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis.
Ranawaka RR; Weerakoon HS; de Silva SH
Int J Dermatol; 2015; 54(5):555-63. PubMed ID: 25600472
[TBL] [Abstract][Full Text] [Related]
3. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
El-Sayed M; Anwar AE
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
[TBL] [Abstract][Full Text] [Related]
4. A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis.
Sharquie KE; Najim RA; Farjou IB
Clin Exp Dermatol; 1997 Jul; 22(4):169-73. PubMed ID: 9499605
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India.
Bumb RA; Mehta RD; Ghiya BC; Jakhar R; Prasad N; Soni P; Lezama-Davila C; Satoskar AR
Br J Dermatol; 2010 Oct; 163(4):854-8. PubMed ID: 20500797
[TBL] [Abstract][Full Text] [Related]
7. A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution.
Sharquie KE
J Dermatol; 1995 Oct; 22(10):732-7. PubMed ID: 8586751
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
[TBL] [Abstract][Full Text] [Related]
9. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
Soto J; Valda-Rodriquez L; Toledo J; Vera-Navarro L; Luz M; Monasterios-Torrico H; Vega J; Berman J
Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous Leishmaniasis.
Almeida R; D'Oliveira A; Machado P; Bacellar O; Ko AI; de Jesus AR; Mobashery N; Brito Santos J; Carvalho EM
J Infect Dis; 1999 Nov; 180(5):1735-7. PubMed ID: 10515844
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis.
Al Hamdi K; Awad AH; Moker HM
East Mediterr Health J; 2010 Jan; 16(1):89-93. PubMed ID: 20214164
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind study on intralesional metronidazole versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis.
Somaratne VN; Ranawaka RR; Jayaruwan HM; Wipuladasa DM; de Silva SHP
J Dermatolog Treat; 2019 Feb; 30(1):87-91. PubMed ID: 29764246
[TBL] [Abstract][Full Text] [Related]
13. Intralesional sodium stibogluconate under inhaled anesthesia for the treatment of cutaneous leishmaniasis in children: A retrospective cohort.
Renert-Yuval Y; Enk CD; Murad S; Yofe V; Gozal D; Molho-Pessach V
J Am Acad Dermatol; 2019 Oct; 81(4):1013-1015. PubMed ID: 30731176
[No Abstract] [Full Text] [Related]
14. Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey.
Uzun S; Durdu M; Culha G; Allahverdiyev AM; Memisoglu HR
J Parasitol; 2004 Aug; 90(4):853-9. PubMed ID: 15357081
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis.
Solomon M; Ollech A; Pavlotsky F; Barzilai A; Schwartz E; Baum S; Astman N
Acta Derm Venereol; 2024 Apr; 104():adv35089. PubMed ID: 38682801
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
Asilian A; Sadeghinia A; Faghihi G; Momeni A; Amini Harandi A
Ann Trop Med Parasitol; 2003 Jul; 97(5):493-8. PubMed ID: 12930612
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Effect Of Oral Allopurinol And Intralesional Sodium Stibogluconate In The Treatment Of Cutaneous Leishmaniasis.
Rashid HU; Ullah I; Adeeb H; Zeb M; Mohammad A; Rehman N
J Ayub Med Coll Abbottabad; 2020; 32(4):558-561. PubMed ID: 33225663
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of single-dose radiofrequency-induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India.
Bumb RA; Prasad N; Khandelwal K; Aara N; Mehta RD; Ghiya BC; Salotra P; Wei L; Peters S; Satoskar AR
Br J Dermatol; 2013 May; 168(5):1114-9. PubMed ID: 23298394
[TBL] [Abstract][Full Text] [Related]
19. [American cutaneous leishmaniasis: special features in diagnosis and therapy].
Bormann G; William T; Schulz A; Marsch W; Gaber G
Dtsch Med Wochenschr; 2003 Oct; 128(40):2065-8. PubMed ID: 14523685
[TBL] [Abstract][Full Text] [Related]
20. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
